Two Sigma Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.7M | Buy |
1,684,055
+1,410,900
| +517% | +$60.9M | 0.15% | 138 |
|
|
2025
Q1 | $9.44M | Buy |
+273,155
| New | +$9.44M | 0.02% | 552 |
|
|
2024
Q4 | – | Sell |
-40,855
| Closed | -$1.04M | – | 2345 |
|
|
2024
Q3 | $1.04M | Sell |
40,855
-211,965
| -84% | -$5.4M | ﹤0.01% | 1392 |
|
|
2024
Q2 | $6.4M | Sell |
252,820
-49,035
| -16% | -$1.24M | 0.01% | 678 |
|
|
2024
Q1 | $9.33M | Sell |
301,855
-59,900
| -17% | -$1.85M | 0.02% | 561 |
|
|
2023
Q4 | $14.6M | Sell |
361,755
-16,300
| -4% | -$658K | 0.03% | 406 |
|
|
2023
Q3 | $9.97M | Sell |
378,055
-17,190
| -4% | -$453K | 0.03% | 468 |
|
|
2023
Q2 | $6.8M | Buy |
395,245
+76,110
| +24% | +$1.31M | 0.02% | 633 |
|
|
2023
Q1 | $5.29M | Buy |
319,135
+77,700
| +32% | +$1.29M | 0.01% | 783 |
|
|
2022
Q4 | $1.84M | Sell |
241,435
-5,265
| -2% | -$40.1K | 0.01% | 1286 |
|
|
2022
Q3 | $2.45M | Buy |
246,700
+205,420
| +498% | +$2.04M | 0.01% | 1067 |
|
|
2022
Q2 | $375K | Buy |
41,280
+13,800
| +50% | +$125K | ﹤0.01% | 2048 |
|
|
2022
Q1 | $279K | Sell |
27,480
-26,455
| -49% | -$269K | ﹤0.01% | 2258 |
|
|
2021
Q4 | $900K | Sell |
53,935
-95,315
| -64% | -$1.59M | ﹤0.01% | 1612 |
|
|
2021
Q3 | $7M | Sell |
149,250
-108,000
| -42% | -$5.06M | 0.02% | 639 |
|
|
2021
Q2 | $15.7M | Sell |
257,250
-189,200
| -42% | -$11.5M | 0.04% | 400 |
|
|
2021
Q1 | $27.5M | Buy |
446,450
+320,550
| +255% | +$19.7M | 0.08% | 278 |
|
|
2020
Q4 | $8.95M | Buy |
+125,900
| New | +$8.95M | 0.02% | 603 |
|